Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein for Risk-Stratification of Patients With TIA
Lipoprotein-Associated Phospholipase A 2 Activity and Risk of Recurrent Stroke
Lipoprotein-Associated Phospholipase A2
Activity Is Associated with Large-Artery Atherosclerotic Etiology and Recurrent Stroke in TIA Patients
Lipoprotein-associated phospholipaseA2 testing usefulness
among patients withsymptomatic
intracranialatheroscleroticdisease